We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ITA Plans May 2015 Medtech Business Development Mission to Middle East

ITA Plans May 2015 Medtech Business Development Mission to Middle East

June 17, 2014

The International Trade Administration is organizing a healthcare equipment, services and technologies business development mission to three Middle Eastern cities, with the aim of introducing U.S. devicemakers and trade groups to the region and promoting products and services.

The entourage will visit Cairo, Tel Aviv and Amman, Jordan, with an optional stop in the West Bank city of Ramallah from May 16 through 21, 2015, according to a Tuesday Federal Register notice.

During the trip, members of the U.S. delegation will participate in customized meetings with prospective partners and receive market briefings. Targeted sectors include:

  • Maternal and child health products and services;
  • Medical equipment and supplies, including diagnostic, monitoring and imaging equipment;
  • Hospital and outpatient clinic design and management;
  • E-health, including healthcare management systems, software and network design;
  • Laboratory and scientific equipment;
  • Products for specialties such as oncology, cardiology, wound care and plastic surgery;
  • Products and services for implementing quality standards and accreditation;
  • Robotics; and
  • Mobile clinics.  

According to the ITA, 2013 healthcare spending in Egypt, Jordan and Israel was $9.5 billion, $1 billion and $20 billion, respectively. Those numbers are expected to grow five to eight percent this year, the ITA says.

Participation is limited to 12 to 15 companies. Selection will be based on the relevance of a company’s business to the mission goals, suitability of its products or services for the respective markets and the potential for business in those markets.

Applications will be accepted on a rolling basis through March 13, 2015. The cost is $3,325 for small businesses and $4,625 for large ones. — Kellen Owings

Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.

Medical Devices Commercial Operations

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 27Jan

    FDA’s Response to COVID-19: Fundamentals of Obtaining Emergency Use Authorizations

  • 09Feb

    Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19

  • 10Feb

    FDA Under the Biden Administration: What’s to Come and What It Will Mean

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Supreme Court Rejects Merck’s Appeal for $2.5 Billion Patent Verdict Reinstatement

  • FDA clears text

    FDA Clears SCC’s Transfusion-Management Software

  • CE mark

    MiRXES Earns CE Mark for COVID-19/Flu Test

  • KitePharma_Logo

    Kite Pharma’s Tecartus Gains UK Recommendation for Lymphoma

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing